Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boyce

Showing results (231-240 of 249) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled TrialsYuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
The Lancet. Microbe|June 25, 2026
Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulationsSiobhonne K J Breen, Sara Cortés-Lara, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NSDeanna Deveson Lucas, Bethany Crane, Amy Wright, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
Journal of STEM Outreach|March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) AcademyJoseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Vaccines|May 28, 2025
Vaccination Schedules Recommended by the Centers for Disease Control and Prevention: From Human-Readable to Machine-ProcessableXia Jing, Hua Min, Yang Gong, et al.
ACS Infectious Diseases|April 9, 2021
Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> Is Predominately Driven by ChloramphenicolNusaibah Abdul Rahim, Yan Zhu, Soon-Ee Cheah, et al.
Drug Safety|January 4, 2015
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision supportRichard T Scheife, Lisa E Hines, Richard D Boyce, et al.
Pageof 25

Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled TrialsYuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
The Lancet. Microbe|June 25, 2026
Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulationsSiobhonne K J Breen, Sara Cortés-Lara, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NSDeanna Deveson Lucas, Bethany Crane, Amy Wright, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
Journal of STEM Outreach|March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) AcademyJoseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Vaccines|May 28, 2025
Vaccination Schedules Recommended by the Centers for Disease Control and Prevention: From Human-Readable to Machine-ProcessableXia Jing, Hua Min, Yang Gong, et al.
ACS Infectious Diseases|April 9, 2021
Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> Is Predominately Driven by ChloramphenicolNusaibah Abdul Rahim, Yan Zhu, Soon-Ee Cheah, et al.
Drug Safety|January 4, 2015
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision supportRichard T Scheife, Lisa E Hines, Richard D Boyce, et al.
Pageof 25